(Q51070794)

28 March 2018

title

Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. (English)

1 reference

28 March 2018

0 references

Yao JK

1

1 reference

28 March 2018

Reddy R

series ordinal

2

1 reference

28 March 2018

van Kammen DP

series ordinal

3

1 reference

28 March 2018

language of work or name

English

0 references

publication date

1 December 2000

1 reference

28 March 2018

published in

Psychiatry Research

1 reference

28 March 2018

volume

97

1 reference

28 March 2018

issue

2-3

1 reference

28 March 2018

page(s)

137-151

1 reference

28 March 2018

Negative symptoms in schizophrenia. Definition and reliability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Glutathione peroxidase and CT scan abnormalities in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Methods for reliable longitudinal observation of behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Effects of the Antioxidant Butylated Hydroxytoluene (BHT) on Mortality in BALB/c Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Effect of Ethoxyquin on the Longevity of C3H Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Albumin standards and the measurement of serum albumin with bromcresol green

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Aging: is oxidative stress a marker or is it causal?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

A fluorescence-based method for measuring total plasma antioxidant capability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Blood cotinine levels as indicators of smoking treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Aging and disease: extending functional life span

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

1 reference

7 January 2021

Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Increased Superoxide Dismutase Activity in Aged Human Cerebrospinal Fluid and Rat Brain Determined by Electron Spin Resonance Spectrometry Using the Spin Trap Method

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Comparison of tests used to distinguish smokers from nonsmokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Oxidative stress and superoxide dismutase in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Free radical pathology and antioxidant defense in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Superoxide dismutase activity in developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

The Nithsdale Schizophrenia Surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Mitochondrial role in cell aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Impaired antioxidant defense at the onset of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Determinants of antioxidant status in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Plasma antioxidants are strongly affected by iron-induced lipid peroxidation in rats subjected to physical exercise and different dietary fats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Free radical pathology in schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Oxidative damage and mitochondrial decay in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Oxidative reactions and schizophrenia: a review-discussion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Antioxidant Potential of Anaerobic Human Plasma: Role of Serum Albumin and Thiols as Scavengers of Carbon Radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Vitamin C status in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Superoxide dismutase activities in aging rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Acute phase proteins in male Chinese schizophrenic patients in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Low superoxide dismutase activity in schizophrenic patients with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Reduced status of plasma total antioxidant capacity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Reduced level of plasma antioxidant uric acid in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

Human plasma glutathione peroxidase and symptom severity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2800%2900230-4

7 January 2021

10.1016/S0165-1781(00)00230-4

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018